genesis slider

In 1997 we saw the future of treatment coming closer...

GENESIS Pharma started its activity in pharmaceutical biotechnology in 1997, at a time when the industry was still at an early development stage, not only in Greece but also in Europe. The company's goal was to combine the rapid progress in science with a successful and innovative business venture, thus paving the way for the creation of a new market. Working with consistency and dedication to this end, GENESIS Pharma became the first Greek pharmaceutical company specializing in the marketing, sales and distribution of biopharmaceutical products and is currently the largest by turnover among Greek companies focusing on innovative branded medicines.

The company’s portfolio consists mainly of innovative pharmaceutical products in the therapeutic areas of Oncology, Hematology, Central Nervous System, Gastroenterology and Nephrology, as a result of collaboration with major multinational pharmaceutical companies. 

In 1999, business activities were expanded in Cyprus through the creation of Genesis Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe, such as Bulgaria, Romania and Croatia. GENESIS Pharma (Cyprus) Ltd, an affiliate company, is now responsible for all international markets and is currently operating, through its subsidiaries, in Bulgaria, Romania and Croatia with the latter entity acting as a hub-office covering the Adriatic Region​ and Malta.
  Over the last years, GENESIS Pharma ranks among the largest pharmaceutical companies operating in the Greek market by turnover, and is firmly amongst the leaders in hospital sales in the country.

Moreover, it is one of the most award-winning Greek companies. Since 2000, GENESIS Pharma has received numerous awards and certifications for its growth and productivity rates as well as its commitment to innovation, quality, corporate responsibility and good working environment.